d’Entremont says the pharmaceutical company is ensuring its supply chain remains 'solid' and is sitting on 3-6 months of prescription drug inventory.
Full interview: Medexus Pharmaceuticals ensuring its prescription drug supply chain remains solid
Quick facts: Medexus Pharmaceuticals Inc
Price: 4.1 CAD
Market Cap: $59.25 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Medexus Pharmaceuticals Inc named herein, including the promotion by the Company of Medexus Pharmaceuticals Inc in any Content on the Site, the...FOR OUR FULL DISCLAIMER CLICK HERE